Found 54 matching trials
Post Transplant Donor Lymphocyte Infusion PHASE2 The purpose of this study is to test the hypothesis that a pre-infusion pre...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). PHASE1 This Phase I/IIa clinical study is testing an experimental treatment called...
Show More Location
Hospital Clínic de Barcelona
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 PHASE1 Breast cancer is the second most common invasive malignancy and the leading...
Show More Learn More & Join Trial
Immunological Tolerance in Patients With Mismatched Kidney Transplants PHASE1 This study seeks to determine if administration of the drug belumosudil (KD...
Show More Status
Active Not Recruiting
Location
University of California, Los Angeles
Learn More & Join Trial
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL PHASE1 ATHENA chimeric antigen receptor (CAR)-T, a CD19-directed CAR-T cell immuno...
Show More Location
Biotherapeutic Department, Chinese PLA General Hospital
Learn More & Join Trial
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors. PHASE1 This is a First in Human muticenter, non-randomized, open-label Phase I dos...
Show More Location
Shizuoka Cancer Center
Learn More & Join Trial
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors NA Stem cells collected from sibling donors for allogenic transplants contain ...
Show More Status
Active Not Recruiting
Location
University of Alabama Hospital
Learn More & Join Trial
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE1 This is a safety / feasibility trial evaluating the combination of a humani...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial